Loading...
Loading...
Sucampo Pharmaceuticals
SCMP (SPI) today announced that
NASDAQ OMX Group, Inc.
NDAQ will include the company in the
NASDAQ Biotechnology Index®
NBI effective prior to
market open on Monday, May 20, 2013.
The NASDAQ Biotechnology Index is designed to track the performance of a
set of securities listed on The NASDAQ Stock Market that are classified
as either biotechnology or pharmaceutical according to the Industry
Classification Benchmark (ICB). The NASDAQ Biotechnology Index is a
modified market capitalization weighted index. Among the various
criteria that must be met in order to be eligible for inclusion in this
index are a market capitalization of at least $200 million and an
average daily trading
See full press release© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in